ACTIVE

SOPHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

14,3 M €

+1381.1% YoY

Gross margin

113 k €

-65.2% YoY

Equity

167,3 M €

+212.8% YoY

Workforce

1,5 ETP

-40.0% YoY

What does SOPHARMA do?

SOPHARMA is a Public limited company incorporated in 2001. Its registered office is in Tervuren. It employs on average 1,5 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0476.391.546

Incorporation

20/12/2001

Legal form

Public limited company

Registered office

Jezus Eiklaan 2A
3080 Tervuren · FlandreSee on map

Contributed capital

52 796 681,99 €

Latest accounts

31/12/2025

Average workforce

1,5 ETP

Joint committees (1)

Contacts

1 public detail availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	113 k €	-65.2%	325 k €	-24.5%	430,3 k €	+104%	211,1 k €	-11.6%	238,8 k €	-19.5%	296,5 k €	-8.8%	325 k €	-1.1%	328,5 k €	-4.5%	344,1 k €	+3.6%	332,1 k €	-2.8%	341,6 k €	-2.5%	350,3 k €	+3.6%	338,1 k €	+12.8%	299,8 k €	+19.9%	250 k €	-11.0%	280,8 k €	+8.6%	258,5 k €	+12.2%	230,3 k €	-4.0%	239,8 k €	+17.4%	204,4 k €
EBITDA	-47,8 k €	-127%	177,8 k €	-39.5%	293,8 k €	+558%	44,7 k €	+108%	-531,2 k €	-506%	130,8 k €	+30.4%	100,4 k €	-43.2%	176,6 k €	-1.6%	179,6 k €	+5.5%	170,2 k €	-8.3%	185,5 k €	-13.6%	214,8 k €	+16.1%	184,9 k €	+11.7%	165,5 k €	+78.9%	92,5 k €	-24.2%	122 k €	+2.3%	119,3 k €	+12.4%	106,2 k €	+23.9%	85,7 k €	-4.0%	89,3 k €
Operating result	-168,7 k €	-367%	63,2 k €	-73.6%	239,7 k €	+1281%	17,4 k €	+103%	-566,2 k €	-1828%	32,8 k €	+2224%	1,4 k €	-98.7%	111,6 k €	-9.9%	123,9 k €	-10.9%	139 k €	-11.6%	157,3 k €	-15.1%	185,3 k €	+28.8%	143,8 k €	+27.3%	113 k €	+1287%	-9,5 k €	-139%	24,6 k €	+3.9%	23,7 k €	+96.0%	12,1 k €	+44.2%	8,4 k €	-61.6%	21,8 k €
Net result	14,3 M €	+1381%	965,3 k €	-13.4%	1,1 M €	-18.9%	1,4 M €	-51.1%	2,8 M €	-90.4%	29,3 M €	+11301%	257,1 k €	+31.1%	196 k €	+14.2%	171,6 k €	+4.8%	163,8 k €	+3.8%	157,7 k €	-17.9%	192 k €	+55.8%	123,3 k €	+26.8%	97,2 k €	+389%	-33,7 k €	-115%	-15,6 k €	-180%	-5,6 k €	+72.0%	-20 k €	-49.6%	-13,3 k €	-223%	10,8 k €
Balance sheet
Equity	167,3 M €	+213%	53,5 M €	+1.8%	52,5 M €	+2.2%	51,4 M €	+2.7%	50 M €	+5.9%	47,2 M €	+3008%	1,5 M €	+20.4%	1,3 M €	+18.4%	1,1 M €	+19.2%	894,7 k €	+22.4%	730,9 k €	+27.5%	573,2 k €	+50.4%	381,1 k €	+47.8%	257,8 k €	+60.5%	160,6 k €	-17.3%	194,3 k €	-7.5%	210 k €	-2.6%	215,6 k €	-8.5%	235,5 k €	-5.4%	248,9 k €
Total assets	172,1 M €	+217%	54,3 M €	+1.3%	53,6 M €	+2.3%	52,4 M €	+2.3%	51,2 M €	+0.2%	51,1 M €	+826%	5,5 M €	+18.0%	4,7 M €	-1.3%	4,7 M €	+5.3%	4,5 M €	+4.8%	4,3 M €	+0.6%	4,3 M €	-1.7%	4,3 M €	-4.1%	4,5 M €	+2.1%	4,4 M €	-2.2%	4,5 M €	+2.1%	4,4 M €	+363%	959 k €	-5.1%	1 M €	+38.1%	731,6 k €
Cash	836,4 k €	+208%	271,9 k €	+76.0%	154,5 k €	-46.8%	290,3 k €	-75.9%	1,2 M €	+264%	329,9 k €	+171%	121,7 k €	+61.7%	75,2 k €	-32.2%	110,9 k €	-61.6%	288,7 k €	+91.3%	150,9 k €	+140%	62,8 k €	-53.6%	135,4 k €	-51.4%	278,4 k €	+101%	138,8 k €	-12.9%	159,3 k €	+289%	41 k €	+43.1%	28,6 k €	-24.5%	37,9 k €	+136%	16,1 k €
Debts	4,6 M €	+480%	800,3 k €	-25.2%	1,1 M €	+8.6%	984,9 k €	-16.2%	1,2 M €	-69.7%	3,9 M €	-2.7%	4 M €	+16.6%	3,4 M €	-7.0%	3,7 M €	+1.9%	3,6 M €	+1.2%	3,6 M €	-3.5%	3,7 M €	-6.2%	3,9 M €	-7.8%	4,3 M €	-0.0%	4,3 M €	-1.5%	4,3 M €	+3.2%	4,2 M €	+474%	732,4 k €	-2.7%	752,5 k €	+66.0%	453,2 k €
Other
Workforce	1,5 ETP	-40.0%	2,5 ETP	+38.9%	1,8 ETP	-28.0%	2,5 ETP	0.0%	2,5 ETP	-7.4%	2,7 ETP	-18.2%	3,3 ETP	+13.8%	2,9 ETP	+3.6%	2,8 ETP	-9.7%	3,1 ETP	+10.7%	2,8 ETP	+12.0%	2,5 ETP	-10.7%	2,8 ETP	+12.0%	2,5 ETP	-21.9%	3,2 ETP	+18.5%	2,7 ETP	0.0%	2,7 ETP	+8.0%	2,5 ETP	0.0%	2,5 ETP	+4.2%	2,4 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 26 ended

Active mandates

CONCELLENT

Managing director · since 10 mai 2026 · until 09 mai 2031 · 0874.495.976

Represented by Sofie Boone

Active

Ended mandates

BEUKENLAAN

Director · since 10 mai 2020 · until 17 juillet 2020 · 0437.826.524

Represented by Betty Brems

Ended

CONCELLENT

Managing director · since 10 mai 2020 · until 09 mai 2026 · 0874.495.976

Represented by Sofie BOONE

Ended

CONCELLENT

Director · since 10 mai 2020 · until 09 mai 2026 · 0874.495.976

Represented by Boone SOFIE

Ended

CONCELLENT

Managing director · since 10 mai 2020 · until 09 mai 2026 · 0874.495.976

Represented by Sofie Boone

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/07/2026	26/05/2025	25/06/2024	14/06/2023	30/09/2022	31/08/2021
General meeting	30/06/2026	05/05/2025	19/06/2024	25/05/2023	28/09/2022	14/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	30/06/2026	30/07/2026	Dutch	PDF
Abridged model	31/12/2024	05/05/2025	26/05/2025	Dutch	PDF
Abridged model	31/12/2023	19/06/2024	25/06/2024	Dutch	PDF
Abridged model	31/12/2022	25/05/2023	14/06/2023	Dutch	PDF
Abridged model	31/12/2021	28/09/2022	30/09/2022	Dutch	PDF
Abridged model	31/12/2020	14/05/2021	31/08/2021	Dutch	PDF
Abridged model	31/12/2019	29/05/2020	06/07/2020	Dutch	PDF
Abridged model	31/12/2018	31/05/2019	19/07/2019	Dutch	PDF
Abridged model	31/12/2017	11/05/2018	28/08/2018	Dutch	PDF
Abridged model	31/12/2016	12/05/2017	12/07/2017	Dutch	PDF
Abridged model	31/12/2015	13/05/2016	22/08/2016	Dutch	PDF
Abridged model	31/12/2014	08/05/2015	09/07/2015	Dutch	PDF
Abridged model	31/12/2013	09/05/2014	04/07/2014	Dutch	PDF
Abridged model	31/12/2012	10/05/2013	01/07/2013	Dutch	PDF
Abridged model	31/12/2011	11/05/2012	22/06/2012	Dutch	PDF
Abridged model	31/12/2010	13/05/2011	21/06/2011	Dutch	PDF
Abridged model	31/12/2009	14/05/2010	13/07/2010	Dutch	PDF
Abridged model	31/12/2008	08/05/2009	08/06/2009	Dutch	PDF
Abridged model	31/12/2007	09/05/2008	11/06/2008	Dutch	PDF
Abridged model	31/12/2006	11/05/2007	12/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 26 ended

Active mandates

CONCELLENT

Managing director · since 10 mai 2026 · until 09 mai 2031 · 0874.495.976

Represented by Sofie Boone

Active

Ended mandates

BEUKENLAAN

Director · since 10 mai 2020 · until 17 juillet 2020 · 0437.826.524

Represented by Betty Brems

Ended

CONCELLENT

Managing director · since 10 mai 2020 · until 09 mai 2026 · 0874.495.976

Represented by Sofie BOONE

Ended

CONCELLENT

Director · since 10 mai 2020 · until 09 mai 2026 · 0874.495.976

Represented by Boone SOFIE

Ended

CONCELLENT

Managing director · since 10 mai 2020 · until 09 mai 2026 · 0874.495.976

Represented by Sofie Boone

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Restructuring22/07/2025
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring22/07/2025
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates22/07/2025
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Restructuring26/05/2025
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring26/05/2025
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates10/08/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/08/2020
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Registered office30/10/2014
MAATSCHAPPELIJKE ZETEL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202514,3 M €↑
30/06/2025
augmentation_capital
30/06/2025
apportBoone Sofie
30/06/2025
splitBoone Sofie
01/01/2025
augmentation_capitalBoone Sofie
2024
Annual accounts 2024965,3 k €↓
2023
Annual accounts 20231,1 M €↓
2022
Annual accounts 20221,4 M €↓
2021
Annual accounts 20212,8 M €↓
2020
Annual accounts 202029,3 M €↑
2019
Annual accounts 2019257,1 k €↑
2018
Annual accounts 2018196 k €↑
2017
Annual accounts 2017171,6 k €↑
2016
Annual accounts 2016163,8 k €↑
2015
Annual accounts 2015157,7 k €↓
2014
Annual accounts 2014192 k €↑
2013
Annual accounts 2013123,3 k €↑
2012
Annual accounts 201297,2 k €↑
2011
Annual accounts 2011-33,7 k €↓
2010
Annual accounts 2010-15,6 k €↓
2009
Annual accounts 2009-5,6 k €↑
2008
Annual accounts 2008-20 k €↓
2007
Annual accounts 2007-13,3 k €↓
2006
Annual accounts 200610,8 k €
20/12/2001
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

SOPHARMA

Overview

What does SOPHARMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline